Var.  Probiotic Yeasts As Etiological Agents Of Oportunistic Infections In Humans

1. Appel-da-Silva M.C., Narvaez G.A., Perez L.R.R., Drehmer L., Lewgoy J.: Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med. Mycol. Case Rep. 18, 15–17 (2017) Appel-da-Silva M.C. Narvaez G.A. Perez L.R.R. Drehmer L. Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment Med. Mycol. Case Rep. 18 15 17 201710.1016/j.mmcr.2017.07.007553739528794958 Search in Google Scholar

2. Ardiani A., Higgins J.P., Hodge J.W.: Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res. 10, 1060–1069 (2010) Ardiani A. Higgins J.P. Hodge J.W. Vaccines based on whole recombinant Saccharomyces cerevisiae cells FEMS Yeast Res. 10 1060 1069 201010.1111/j.1567-1364.2010.00665.x729509220707820 Search in Google Scholar

3. Atıcı S., Soysal A., Karadeniz Cerit K., Yılmaz Ş., Aksu B., Kıyan G., Bakır M.: Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature. Med. Mycol. Case Rep. 15, 33–35 (2017) Atıcı S. Soysal A. Karadeniz Cerit K. Yılmaz Ş. Aksu B. Kıyan G. Bakır M. Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature Med. Mycol. Case Rep. 15 33 35 201710.1016/j.mmcr.2017.02.002533350528280685 Search in Google Scholar

4. Balakrishnan R., Park J., Karra K., Hitz B.C., Binkley G., Hong E.L., Sullivan J., Micklem G., Cherry J.M.: Yeast Mine-an integrated data warehouse for Saccharomyces cerevisiae data as a multipurpose tool-kit. Database: the journal of biological databases and curation, 2012, bar062-bar062 (2012) Balakrishnan R. Park J. Karra K. Hitz B.C. Binkley G. Hong E.L. Sullivan J. Micklem G. Cherry J.M. Yeast Mine-an integrated data warehouse for Saccharomyces cerevisiae data as a multipurpose tool-kit Database: the journal of biological databases and curation 2012 bar062-bar062 2012 Search in Google Scholar

5. Barnett J.A.: A history of research on yeasts 10: foundations of yeast genetics. Yeast, 24, 799–845 (2007) Barnett J.A. A history of research on yeasts 10: foundations of yeast genetics Yeast 24 799 845 200710.1002/yea.151317638318 Search in Google Scholar

6. Bassetti S., Frei R., Zimmerli W.: Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am. J. Med. 105, 71–72 (1998) Bassetti S. Frei R. Zimmerli W. Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii Am. J. Med. 105 71 72 199810.1016/S0002-9343(98)00133-89688023 Search in Google Scholar

7. Berg R., Bernasconi P., Fowler D., Gautreaux M.: Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J. Infect. Dis. 168, 1314–1318 (1993) Berg R. Bernasconi P. Fowler D. Gautreaux M. Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii J. Infect. Dis. 168 1314 1318 199310.1093/infdis/168.5.13148228371 Search in Google Scholar

8. Berg R.D.: Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 3, 149–154 (1995) Berg R.D. Bacterial translocation from the gastrointestinal tract Trends Microbiol. 3 149 154 199510.1007/978-1-4615-4143-1_210659341 Search in Google Scholar

9. Bernardi T.L., de Melo Pereira G.V., Cardoso P.G., Dias E.S., Schwan R.F.: Saccharomyces cerevisiae strains associated with the production of cachaça: identification and characterization by traditional and molecular methods (PCR, PFGE and mtDNA-RFLP). World J. Microb. Biot. 24, 2705–2712 (2008) Bernardi T.L. de Melo Pereira G.V. Cardoso P.G. Dias E.S. Schwan R.F. Saccharomyces cerevisiae strains associated with the production of cachaça: identification and characterization by traditional and molecular methods (PCR, PFGE and mtDNA-RFLP) World J. Microb. Biot. 24 2705 2712 200810.1007/s11274-008-9799-y Search in Google Scholar

10. Bharadwaj P., Martins R., Macreadie I.: Yeast as a model for studying Alzheimer’s disease. FEMS Yeast Res. 10, 961–969 (2010) Bharadwaj P. Martins R. Macreadie I. Yeast as a model for studying Alzheimer’s disease FEMS Yeast Res. 10 961 969 201010.1111/j.1567-1364.2010.00658.x20618869 Search in Google Scholar

11. Bongomin F., Gago S., Oladele R.O., Denning D.W.: Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi (Basel), 3(4), pii: E57 (2017) Bongomin F. Gago S. Oladele R.O. Denning D.W. Global and multi-national prevalence of fungal diseases-estimate precision J. Fungi (Basel) 34 pii: E57 201710.3390/jof3040057575315929371573 Search in Google Scholar

12. Botstein D., Fink G.R.: Yeast: an experimental organism for 21st century biology. Genetics, 189, 695–704 (2011) Botstein D. Fink G.R. Yeast: an experimental organism for 21^st century biology Genetics 189 695 704 201110.1534/genetics.111.130765321336122084421 Search in Google Scholar

13. Boucaud C., Berrada K., Bouletreau P.: Septicémie à Saccharomyces boulardii après administration orale d’ultra-levure. Re’an-Urgences, 5:665 (1996) Boucaud C. Berrada K. Bouletreau P. Septicémie à Saccharomyces boulardii après administration orale d’ultra-levure Re’an-Urgences 5 665 199610.1016/S1164-6756(05)80583-3 Search in Google Scholar

14. Breves G., Walter C., Burmester M., Schröder B.: In vitro studies on the effects of Saccharomyces boulardii and Bacillus cereus var. toyoi on nutrient transport in pig jejunum. J. Anim. Physiol. An. N. 84, 9–20 (2000) Breves G. Walter C. Burmester M. Schröder B. In vitro studies on the effects of Saccharomyces boulardii and Bacillus cereus var. toyoi on nutrient transport in pig jejunum J. Anim. Physiol. An. N. 84 9 20 200010.1046/j.1439-0396.2000.00277.x Search in Google Scholar

15. Burkhardt O., Köhnlein T., Pletz M., Welte T.: Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand. J. Infect. Dis. 37, 69–72 (2005) Burkhardt O. Köhnlein T. Pletz M. Welte T. Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole Scand. J. Infect. Dis. 37 69 72 200510.1080/0036554051002645415764194 Search in Google Scholar

16. Buts J.-P., Dekeyser N., Stilmant C., Delem E., Smets F., Sokal E.: Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60, 24–29 (2006) Buts J.-P. Dekeyser N. Stilmant C. Delem E. Smets F. Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation Pediatr. Res. 60 24 29 200610.1203/01.pdr.0000220322.31940.2916690953 Search in Google Scholar

17. Buts J.P., Bernasconi P., Vaerman J.P., Dive C.: Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig. Dis. Sci. 35, 251–256 (1990) Buts J.P. Bernasconi P. Vaerman J.P. Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii Dig. Dis. Sci. 35 251 256 199010.1007/BF015367712302983 Search in Google Scholar

18. Cárdenas P.A., Garcés D., Prado-Vivar B., Flores N., Fornasini M., Cohen H., Salvador I., Cargua O., Baldeón M.E.: Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome. Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-020-03854-3 (2020) Cárdenas P.A. Garcés D. Prado-Vivar B. Flores N. Fornasini M. Cohen H. Salvador I. Cargua O. Baldeón M.E. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-020-03854-3 202032125555 Open DOI Search in Google Scholar

19. Cassone M., Serra P., Mondello F., Girolamo A., Scafetti S., Pistella E., Venditti M.: Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J. Clin. Microbiol. 41, 5340–5343 (2003) Cassone M. Serra P. Mondello F. Girolamo A. Scafetti S. Pistella E. Venditti M. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism J. Clin. Microbiol. 41 5340 5343 200310.1128/JCM.41.11.5340-5343.200326246614605200 Search in Google Scholar

20. Castagliuolo I., Valenick L., Riegler M., LaMont J.T., Pothoulakis C.: Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa. Gastroenterology, 114, A948–A949 (1998) Castagliuolo I. Valenick L. Riegler M. LaMont J.T. Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin a and b-induced effects in human colonic mucosa Gastroenterology 114 A948 A949 199810.1016/S0016-5085(98)83862-6 Search in Google Scholar

21. Cavalieri D., McGovern P.E., Hartl D.L., Mortimer R., Polsinelli M.: Evidence for S. cerevisiae fermentation in ancient wine. J. Mol. Evol., 57 Suppl 1, S226–232 (2003) Cavalieri D. McGovern P.E. Hartl D.L. Mortimer R. Polsinelli M. Evidence for S. cerevisiae fermentation in ancient wine J. Mol. Evol. 57 Suppl 1 S226 232 200310.1007/s00239-003-0031-215008419 Search in Google Scholar

22. Cesaro S., Chinello P., Rossi L., Zanesco L.: Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer, 8, 504–505 (2000) Cesaro S. Chinello P. Rossi L. Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii Support Care Cancer 8 504 505 200010.1007/s00520000012311094997 Search in Google Scholar

23. Chakravarty S., Parashar A., Acharyya S.: Saccharomyces cerevisiae sepsis following probiotic therapy in an infant. Indian Pediatr. 56, 971–972 (2019) Chakravarty S. Parashar A. Acharyya S. Saccharomyces cerevisiae sepsis following probiotic therapy in an infant Indian Pediatr. 56 971 972 201910.1007/s13312-019-1655-7 Search in Google Scholar

24. Chen L., Oshima J.: Werner Syndrome. J. Biomed. Biotechnol. 2, 46–54 (2002) Chen L. Oshima J. Werner Syndrome J. Biomed. Biotechnol. 2 46 54 200210.1155/S111072430220101115378412488583 Search in Google Scholar

25. Chen X., Kokkotou E.G., Mustafa N., Bhaskar K.R., Sougioultzis S., O’Brien M., Pothoulakis C., Kelly C.P.: Saccharomyces boulardii Inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin a-induced enteritis. J. Biol. Chem. 281, 24449–24454 (2006) Chen X. Kokkotou E.G. Mustafa N. Bhaskar K.R. Sougioultzis S. O’Brien M. Pothoulakis C. Kelly C.P. Saccharomyces boulardii Inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin a-induced enteritis J. Biol. Chem. 281 24449 24454 200610.1074/jbc.M60520020016816386 Search in Google Scholar

26. Cherifi S., Robberecht J., Miendje Y.: Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis. Acta Clin. Belg. 59, 223–224 (2004) Cherifi S. Robberecht J. Miendje Y. Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis Acta Clin. Belg. 59 223 224 200410.1179/acb.2004.03315597730 Search in Google Scholar

27. Choi C.H., Jo S.Y., Park H.J., Chang S.K., Byeon J.-S., Myung S.-J.: A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. J. Clin. Gastroenterol. 45, 679–683 (2011) Choi C.H. Jo S.Y. Park H.J. Chang S.K. Byeon J.-S. Myung S.-J. A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life J. Clin. Gastroenterol. 45 679 683 201110.1097/MCG.0b013e318204593e21301358 Search in Google Scholar

28. Cohen L., Ranque S., Raoult D.: Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation. Med. Mycol. Case Rep. 2, 63–64 (2013) Cohen L. Ranque S. Raoult D. Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation Med. Mycol. Case Rep. 2 63 64 201310.1016/j.mmcr.2013.02.003388594924432219 Search in Google Scholar

29. Colak T., Ipek T., Paksoy M., Polat E., Uygun N., Kayabaşi B.: The effects of cefephim, G-CSF, and sucralfate on bacterial translocation in experimentally induced acute pancreatitis. Surg. Today, 31, 502–506 (2001) Colak T. Ipek T. Paksoy M. Polat E. Uygun N. Kayabaşi B. The effects of cefephim, G-CSF, and sucralfate on bacterial translocation in experimentally induced acute pancreatitis Surg. Today 31 502 506 200110.1007/s00595017010911428601 Search in Google Scholar

30. Costa R.L., Moreira J., Lorenzo A., Lamas C.C.: Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern. Med. 18, 329 (2018) Costa R.L. Moreira J. Lorenzo A. Lamas C.C. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series BMC Complement Altern. Med. 18 329 201810.1186/s12906-018-2394-3629212030541524 Search in Google Scholar

31. Czerucka D., Piche T., Rampal P.: Review article: yeast as probiotics – Saccharomyces boulardii. Aliment. Pharmacol. Ther. 26, 767–778 (2007) Czerucka D. Piche T. Rampal P. Review article: yeast as probiotics – Saccharomyces boulardii Aliment. Pharmacol. Ther. 26 767 778 200710.1111/j.1365-2036.2007.03442.x17767461 Search in Google Scholar

32. Czerucka D., Roux I., Rampal P.: Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’,5’-cyclic monophosphate induction in intestinal cells. Gastroenterology, 106, 65–72 (1994) Czerucka D. Roux I. Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’,5’-cyclic monophosphate induction in intestinal cells Gastroenterology 106 65 72 199410.1016/S0016-5085(94)94403-28276210 Search in Google Scholar

33. Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., Czerucka D.: Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect. Immun. 71, 766–773 (2003) Dahan S. Dalmasso G. Imbert V. Peyron J.F. Rampal P. Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells Infect. Immun. 71 766 773 200310.1128/IAI.71.2.766-773.200314535512540556 Search in Google Scholar

34. Dalmasso G., Cottrez F., Imbert V., Lagadec P., Peyron J.F., Rampal P., Czerucka D., Groux H., Foussat A., Brun V.: Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology, 131, 1812–1825 (2006) Dalmasso G. Cottrez F. Imbert V. Lagadec P. Peyron J.F. Rampal P. Czerucka D. Groux H. Foussat A. Brun V. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes Gastroenterology 131 1812 1825 200610.1053/j.gastro.2006.10.00117087945 Search in Google Scholar

35. Dauby N.: Risks of Saccharomyces boulardii-containing probiotics for the prevention of Clostridium difficile infection in the elderly. Gastroenterology, 153, 1450–1451 (2017) Dauby N. Risks of Saccharomyces boulardii-containing probiotics for the prevention of Clostridium difficile infection in the elderly Gastroenterology 153 1450 1451 201710.1053/j.gastro.2017.04.05428988917 Search in Google Scholar

36. de Llanos R., Llopis S., Molero G., Querol A., Gil C., Fernández-Espinar M.T.: In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits. Int. J. Food Microbiol. 144, 393–399 (2011) de Llanos R. Llopis S. Molero G. Querol A. Gil C. Fernández-Espinar M.T. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits Int. J. Food Microbiol. 144 393 399 201110.1016/j.ijfoodmicro.2010.10.02521081253 Search in Google Scholar

37. de Llanos R., Querol A., Pemán J., Gobernado M., Fernández-Espinar M.T.: Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int. J. Food Microbiol. 110, 286–290 (2006) de Llanos R. Querol A. Pemán J. Gobernado M. Fernández-Espinar M.T. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections Int. J. Food Microbiol. 110 286 290 200610.1016/j.ijfoodmicro.2006.04.02316782223 Search in Google Scholar

38. Domingues L., Oliveira C., Castro I., Lima N., Teixeira A.J.: Production of β-galactosidase from recombinant Saccharomyces cerevisiae grown on lactose. J. Chem. Technol. Biot. 79, 809–815 (2004) Domingues L. Oliveira C. Castro I. Lima N. Teixeira A.J. Production of β-galactosidase from recombinant Saccharomyces cerevisiae grown on lactose J. Chem. Technol. Biot. 79 809 815 200410.1002/jctb.1025 Search in Google Scholar

39. Edwards-Ingram L., Gitsham P., Burton N., Warhurst G., Clarke I., Hoyle D., Oliver S.G., Stateva L.: Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl. Environ. Microbiol. 73, 2458–2467 (2007) Edwards-Ingram L. Gitsham P. Burton N. Warhurst G. Clarke I. Hoyle D. Oliver S.G. Stateva L. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae Appl. Environ. Microbiol. 73 2458 2467 200710.1128/AEM.02201-06185559417293506 Search in Google Scholar

40. Ellouze O., Berthoud V., Mervant M., Parthiot J.P., Girard C.: Septic shock due to Saccharomyces boulardii. Med. Mal. Infect. 46, 104–105 (2016) Ellouze O. Berthoud V. Mervant M. Parthiot J.P. Girard C. Septic shock due to Saccharomyces boulardii Med. Mal. Infect. 46 104 105 201610.1016/j.medmal.2015.12.00326774277 Search in Google Scholar

41. Elmer G.W., Surawicz C.M., McFarland L.V.: Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA, 275, 870–876 (1996) Elmer G.W. Surawicz C.M. McFarland L.V. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections JAMA 275 870 876 199610.1001/jama.275.11.8708596226 Search in Google Scholar

42. Enache-Angoulvant A., Hennequin C.: Invasive Saccharomyces infection: a comprehensive review. Clin. Infect. Dis. 41, 1559–1568 (2005) Enache-Angoulvant A. Hennequin C. Invasive Saccharomyces infection: a comprehensive review Clin. Infect. Dis. 41 1559 1568 200510.1086/49783216267727 Search in Google Scholar

43. Eren Z., Gurol Y., Sonmezoglu M., Eren H.S., Celik G., Kantarci G.: [Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment]. Mikrobiyol Bul. 48, 351–355 (2014) Eren Z. Gurol Y. Sonmezoglu M. Eren H.S. Celik G. Kantarci G. [Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment] Mikrobiyol Bul. 48 351 355 201410.5578/mb.697024819274 Search in Google Scholar

44. Fadhel M., Patel S., Liu E., Levitt M., Asif A.: Fungemia in a critically ill patient with acute cholangitis and long term probiotic use. Med. Mycol. Case Rep. 23, 23–25 (2019) Fadhel M. Patel S. Liu E. Levitt M. Asif A. Fungemia in a critically ill patient with acute cholangitis and long term probiotic use Med. Mycol. Case Rep. 23 23 25 201910.1016/j.mmcr.2018.11.003625179130505677 Search in Google Scholar

45. Fietto J.L.R., Araújo R.S., Valadão F.N., Fietto L.G., Brandão R.L., Neves M.J., Gomes F.C.O., Nicoli J.R., Castro I.M.: Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can. J. Microbiol. 50, 615–621 (2004) Fietto J.L.R. Araújo R.S. Valadão F.N. Fietto L.G. Brandão R.L. Neves M.J. Gomes F.C.O. Nicoli J.R. Castro I.M. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii Can. J. Microbiol. 50 615 621 200410.1139/w04-05015467787 Search in Google Scholar

46. Fredenucci I., Chomarat M., Boucaud C., Flandrois J.P.: Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin. Infect. Dis. 27, 222–223 (1998) Fredenucci I. Chomarat M. Boucaud C. Flandrois J.P. Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy Clin. Infect. Dis. 27 222 223 199810.1086/5176859675488 Search in Google Scholar

47. Geyik M.F., Aldemir M., Hosoglu S., Ayaz C., Satilmis S., Buyukbayram H., Kokoglu O.F.: The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice. Ann. R. Coll. Surg. Engl. 88, 176–180 (2006) Geyik M.F. Aldemir M. Hosoglu S. Ayaz C. Satilmis S. Buyukbayram H. Kokoglu O.F. The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice Ann. R. Coll. Surg. Engl. 88 176 180 200610.1308/003588406X94986196404016551414 Search in Google Scholar

48. Girardin S.E., Philpott D.J. i wsp.: CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Reports, 2, 736–742 (2001) Girardin S.E. Philpott D.J. i wsp. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri EMBO Reports 2 736 742 200110.1093/embo-reports/kve155108399211463746 Search in Google Scholar

49. Giusto C., Iacumin L., Comi G., Buiatti S., Manzano M.: PCR-TTGE and RAPD-PCR Techniques to analyze Saccharomyces cerevisiae and Saccharomyces carlsbergensis isolated from craft beers. J. I. Brewing, 112, 340–345 (2006) Giusto C. Iacumin L. Comi G. Buiatti S. Manzano M. PCR-TTGE and RAPD-PCR Techniques to analyze Saccharomyces cerevisiae and Saccharomyces carlsbergensis isolated from craft beers J. I. Brewing 112 340 345 200610.1002/j.2050-0416.2006.tb00740.x Search in Google Scholar

50. Goffeau A., Oliver S.G. i wsp.: Life with 6000 genes. Science, 274, 546, 563–547 (1996) Goffeau A. Oliver S.G. i wsp. Life with 6000 genes Science 274 546 563 547 199610.1126/science.274.5287.5468849441 Search in Google Scholar

51. Gokhale K.C., Newnam G.P., Sherman M.Y., Chernoff Y.O.: Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model. J. Biol. Chem. 280, 22809–22818 (2005) Gokhale K.C. Newnam G.P. Sherman M.Y. Chernoff Y.O. Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model J. Biol. Chem. 280 22809 22818 200510.1074/jbc.M50039020015824100 Search in Google Scholar

52. Graf C., Gavazzi G.: Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. J. Infect. 54, 310–311 (2007) Graf C. Gavazzi G. Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation J. Infect. 54 310 311 200710.1016/j.jinf.2006.01.01916545460 Search in Google Scholar

53. Graff S., Chaumeil J.C., Boy P., Lai-Kuen R., Charrueau C.: Influence of pH conditions on the viability of Saccharomyces boulardii yeast. J. Gen. Appl. Microbiol. 54, 221–227 (2008) Graff S. Chaumeil J.C. Boy P. Lai-Kuen R. Charrueau C. Influence of pH conditions on the viability of Saccharomyces boulardii yeast J. Gen. Appl. Microbiol. 54 221 227 200810.2323/jgam.54.22118802321 Search in Google Scholar

54. Gupta P., Singh Y.P., Taneja A.: A friend or foe in ICU (A case report with solution). Indian J. Crit. Care Med. 23, 430–431 (2019) Gupta P. Singh Y.P. Taneja A. A friend or foe in ICU (A case report with solution) Indian J. Crit. Care Med. 23 430 431 201910.5005/jp-journals-10071-23239677572331645830 Search in Google Scholar

55. Guslandi M.: Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis. J. Clin. Gastroenterol. 44, 385 (2010) Guslandi M. Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis J. Clin. Gastroenterol. 44 385 201010.1097/MCG.0b013e3181cb423320104184 Search in Google Scholar

56. Guslandi M.: Treatment of irritable bowel syndrome with Saccharomyces boulardii. J. Clin. Gastroenterol. 45, 740–741 (2011) Guslandi M. Treatment of irritable bowel syndrome with Saccharomyces boulardii J. Clin. Gastroenterol. 45 740 741 201110.1097/MCG.0b013e3182166c7621555955 Search in Google Scholar

57. Hackel B.J., Huang D., Bubolz J.C., Wang X.X., Shusta E.V.: Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae. Pharm. Res. 23, 790–797 (2006) Hackel B.J. Huang D. Bubolz J.C. Wang X.X. Shusta E.V. Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae Pharm. Res. 23 790 797 200610.1007/s11095-006-9778-716550469 Search in Google Scholar

58. Hayford A.E., Jespersen L.: Characterization of Saccharomyces cerevisiae strains from spontaneously fermented maize dough by profiles of assimilation, chromosome polymorphism, PCR and MAL genotyping. J. Appl. Microbiol. 86, 284–294 (1999) Hayford A.E. Jespersen L. Characterization of Saccharomyces cerevisiae strains from spontaneously fermented maize dough by profiles of assimilation, chromosome polymorphism, PCR and MAL genotyping J. Appl. Microbiol. 86 284 294 199910.1046/j.1365-2672.1999.00653.x10063628 Search in Google Scholar

59. Hennequin C., Kauffmann-Lacroix C., Jobert A., Viard J.P., Ricour C., Jacquemin J.L., Berche P.: Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 19, 16–20 (2000) Hennequin C. Kauffmann-Lacroix C. Jobert A. Viard J.P. Ricour C. Jacquemin J.L. Berche P. Possible role of catheters in Saccharomyces boulardii fungemia Eur. J. Clin. Microbiol. Infect. Dis. 19 16 20 200010.1007/s10096005000310706174 Search in Google Scholar

60. Hennequin C., Thierry A., Richard G.F., Lecointre G., Nguyen H.V., Gaillardin C., Dujon B.: Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains. J. Clin. Microbiol. 39, 551–559 (2001) Hennequin C. Thierry A. Richard G.F. Lecointre G. Nguyen H.V. Gaillardin C. Dujon B. Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains J. Clin. Microbiol. 39 551 559 200110.1128/JCM.39.2.551-559.20018777411158105 Search in Google Scholar

61. Henry S., D’Hondt L., André M., Holemans X., Canon J.L.: Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature. Acta Clin. Belg. 59, 220–222 (2004) Henry S. D’Hondt L. André M. Holemans X. Canon J.L. Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature Acta Clin. Belg. 59 220 222 200410.1179/acb.2004.03215597729 Search in Google Scholar

62. Herbrecht R., Nivoix Y.: Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clin. Infect. Dis. 40, 1635–1637 (2005) Herbrecht R. Nivoix Y. Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration Clin. Infect. Dis. 40 1635 1637 200510.1086/42992615889361 Search in Google Scholar

63. Hermans D., De Keyser N., Marandi S., Chae Y.H.E., Lambotte L., Buts J.-P.: Saccharomyces boulardii upgrades cellular adaptation following proximal enterectomy in rats. Pediatr. Res. 45, 112–112 (1999) Hermans D. De Keyser N. Marandi S. Chae Y.H.E. Lambotte L. Buts J.-P. Saccharomyces boulardii upgrades cellular adaptation following proximal enterectomy in rats Pediatr. Res. 45 112 112 199910.1203/00006450-199904020-00664 Search in Google Scholar

64. Herschleb J., Ananiev G., Schwartz D.C.: Pulsed-field gel electrophoresis. Nature Protocols, 2, 677–684 (2007) Herschleb J. Ananiev G. Schwartz D.C. Pulsed-field gel electrophoresis Nature Protocols 2 677 684 200710.1038/nprot.2007.9417406630 Search in Google Scholar

65. Imre A., Rácz H.V., Antunovics Z., Rádai Z., Kovács R., Lopandic K., Pócsi I., Pfliegler W.P.: A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates. Microbiol. Res. 227, 126298 (2019) Imre A. Rácz H.V. Antunovics Z. Rádai Z. Kovács R. Lopandic K. Pócsi I. Pfliegler W.P. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates Microbiol. Res. 227 126298 201910.1016/j.micres.2019.12629831421716 Search in Google Scholar

66. Kara I., Yıldırım F., Özgen Ö., Erganiş S., Aydoğdu M., Dizbay M., Gürsel G., Kalkanci A.: Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient. J. Mycol. Med. 28, 218–221 (2018) Kara I. Yıldırım F. Özgen Ö. Erganiş S. Aydoğdu M. Dizbay M. Gürsel G. Kalkanci A. Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient J. Mycol. Med. 28 218 221 201810.1016/j.mycmed.2017.09.00329132794 Search in Google Scholar

67. Kazachenko K.Y.E., B. D. Kozlov, D. G.: Activities of elements of the yeast α-factor precursor leader at different stages of somatropin secretion by Saccharomyces cerevisiae. Appl. Biochem. 50, 829–834 (2014) Kazachenko K.Y.E. Kozlov B. D. D. G. Activities of elements of the yeast α-factor precursor leader at different stages of somatropin secretion by Saccharomyces cerevisiae Appl. Biochem. 50 829 834 201410.1134/S000368381409004X Search in Google Scholar

68. Khatri I., Tomar R., Ganesan K., Prasad G.S., Subramanian S.: Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii. Sci. Rep. 7, 371 (2017) Khatri I. Tomar R. Ganesan K. Prasad G.S. Subramanian S. Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii Sci. Rep. 7 371 201710.1038/s41598-017-00414-2542847928336969 Search in Google Scholar

69. Kim M.D., Han K.C., Kang H.A., Rhee S.K., Seo J.H.: Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae. J. Biotechnol. 101, 81–87 (2003) Kim M.D. Han K.C. Kang H.A. Rhee S.K. Seo J.H. Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiae J. Biotechnol. 101 81 87 200310.1016/S0168-1656(02)00288-2 Search in Google Scholar

70. Kjeldsen T.: Yeast secretory expression of insulin precursors. Appl. Microbiol. Biotechnol. 54, 277–286 (2000) Kjeldsen T. Yeast secretory expression of insulin precursors Appl. Microbiol. Biotechnol. 54 277 286 200010.1007/s00253000040211030562 Search in Google Scholar

71. Klingberg T.D., Lesnik U., Arneborg N., Raspor P., Jespersen L.: Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res. 8, 631–640 (2008) Klingberg T.D. Lesnik U. Arneborg N. Raspor P. Jespersen L. Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits FEMS Yeast Res. 8 631 640 200810.1111/j.1567-1364.2008.00365.x243033218355272 Search in Google Scholar

72. Kumar R., Kumar P.: Yeast-based vaccines: New perspective in vaccine development and application. FEMS Yeast Res. 19, pii: foz007 (2019) Kumar R. Kumar P. Yeast-based vaccines: New perspective in vaccine development and application FEMS Yeast Res. 19 pii: foz007 201910.1093/femsyr/foz00730668686 Search in Google Scholar

73. Lestin F., Pertschy A., Rimek D.: [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities]. Dtsch. Med. Wochenschr. 128, 2531–2533 (2003) Lestin F. Pertschy A. Rimek D. [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities] Dtsch. Med. Wochenschr. 128 2531 2533 2003 Search in Google Scholar

74. Lherm T., Monet C., Nougière B., Soulier M., Larbi D., Le Gall C., Caen D., Malbrunot C.: Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 28, 797–801 (2002) Lherm T. Monet C. Nougière B. Soulier M. Larbi D. Le Gall C. Caen D. Malbrunot C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients Intensive Care Med. 28 797 801 200210.1007/s00134-002-1267-912107689 Search in Google Scholar

75. Liti G.: The fascinating and secret wild life of the budding yeast S. cerevisiae. Elife, 4, (2015) Liti G. The fascinating and secret wild life of the budding yeast S. cerevisiae Elife 4 201510.7554/eLife.05835437346125807086 Search in Google Scholar

76. Lolis N., Veldekis D., Moraitou H., Kanavaki S., Velegraki A., Triandafyllidis C., Tasioudis C., Pefanis A., Pneumatikos I.: Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit. Care, 12, 414 (2008) Lolis N. Veldekis D. Moraitou H. Kanavaki S. Velegraki A. Triandafyllidis C. Tasioudis C. Pefanis A. Pneumatikos I. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin Crit. Care 12 414 200810.1186/cc6843244758018423057 Search in Google Scholar

77. Lungarotti M.S., Mezzetti D., Radicioni M.: Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida. Arch. Dis. Child Fetal Neonatal. Ed. 88, F446 (2003) Lungarotti M.S. Mezzetti D. Radicioni M. Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida Arch. Dis. Child Fetal Neonatal. Ed. 88 F446 200310.1136/fn.88.5.F446 Search in Google Scholar

78. Luo J., He M., Li W., Zhang T.: Expression and secretion of alpha-amylase and glucoamylase in Saccharomyces cerevisiae. Chin. J. Biotechnol. 10, 241–248 (1994) Luo J. He M. Li W. Zhang T. Expression and secretion of alpha-amylase and glucoamylase in Saccharomyces cerevisiae Chin. J. Biotechnol. 10 241 248 1994 Search in Google Scholar

79. Łukaszewicz M.: Saccharomyces cerevisiae var. boulardii – probiotic yeast. (w) Probiotics, red. Rigobelo E., IntechOpen, Londyn, Wielka Brytania (2012) Łukaszewicz M. Saccharomyces cerevisiae var. boulardii – probiotic yeast. (w) Probiotics red. Rigobelo E. IntechOpen Londyn, Wielka Brytania 201210.5772/50105 Search in Google Scholar

80. Martin G.S., Mannino D.M., Eaton S., Moss M.: The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546–1554 (2003) Martin G.S. Mannino D.M. Eaton S. Moss M. The epidemiology of sepsis in the United States from 1979 through 2000 N. Engl. J. Med. 348 1546 1554 200310.1056/NEJMoa02213912700374 Search in Google Scholar

81. Martin I.W., Zhang S.X. i wsp.: Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic’s use. Diagn. Microbiol. Infect. Dis. 87, 286–288 (2017) Martin I.W. Zhang S.X. i wsp. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic’s use Diagn. Microbiol. Infect. Dis. 87 286 288 201710.1016/j.diagmicrobio.2016.12.00428024866 Search in Google Scholar

82. Martinez M.J., Roy S., Archuletta A.B., Wentzell P.D., Anna-Arriola S.S., Rodriguez A.L., Aragon A.D., Quiñones G.A., Allen C., Werner-Washburne M.: Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene expression and identification of novel essential genes. Mol. Biol. Cell, 15, 5295–5305 (2004) Martinez M.J. Roy S. Archuletta A.B. Wentzell P.D. Anna-Arriola S.S. Rodriguez A.L. Aragon A.D. Quiñones G.A. Allen C. Werner-Washburne M. Genomic analysis of stationary-phase and exit in Saccharomyces cerevisiae: gene expression and identification of novel essential genes Mol. Biol. Cell 15 5295 5305 200410.1091/mbc.e03-11-085653201115456898 Search in Google Scholar

83. Martins F.S., Teixeira M.M. i wsp.: Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes and Infection, 15, 270–279 (2013) Martins F.S. Teixeira M.M. i wsp. Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice Microbes and Infection 15 270 279 201310.1016/j.micinf.2012.12.00723376166 Search in Google Scholar

84. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R.: Human hepatitis B vaccine from recombinant yeast. Nature, 307, 178–180 (1984) McAleer W.J. Buynak E.B. Maigetter R.Z. Wampler D.E. Miller W.J. Hilleman M.R. Human hepatitis B vaccine from recombinant yeast Nature 307 178 180 198410.1038/307178a06318124 Search in Google Scholar

85. McCullough M.J., Clemons K.V., McCusker J.H., Stevens D.A.: Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J. Clin. Microbiol. 36, 2613–2617 (1998) McCullough M.J. Clemons K.V. McCusker J.H. Stevens D.A. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.) J. Clin. Microbiol. 36 2613 2617 199810.1128/JCM.36.9.2613-2617.19981051729705402 Search in Google Scholar

86. McFarland L.V.: Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16, 2202–2222 (2010) McFarland L.V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients World J. Gastroenterol. 16 2202 2222 201010.3748/wjg.v16.i18.2202286821320458757 Search in Google Scholar

87. Mitterdorfer G., Mayer H.K., Kneifel W., Viernstein H.: Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. J. Appl. Microbiol. 93, 521–530 (2002) Mitterdorfer G. Mayer H.K. Kneifel W. Viernstein H. Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques J. Appl. Microbiol. 93 521 530 200210.1046/j.1365-2672.2002.01710.x12234334 Search in Google Scholar

88. Molnar O., Messner R., Prillinger H., Stahl U., Slavikova E.: Genotypic identification of Saccharomyces species using random amplified polymorphic DNA analysis. Syst. Appl. Microbiol. 18, 136–145 (1995) Molnar O. Messner R. Prillinger H. Stahl U. Slavikova E. Genotypic identification of Saccharomyces species using random amplified polymorphic DNA analysis Syst. Appl. Microbiol. 18 136 145 199510.1016/S0723-2020(11)80461-3 Search in Google Scholar

89. Moriguchi K., Yamamoto S., Tanaka K., Kurata N., Suzuki K.: Trans-kingdom horizontal DNA transfer from bacteria to yeast is highly plastic due to natural polymorphisms in auxiliary nonessential recipient genes. PLoS One, 8, e74590 (2013) Moriguchi K. Yamamoto S. Tanaka K. Kurata N. Suzuki K. Trans-kingdom horizontal DNA transfer from bacteria to yeast is highly plastic due to natural polymorphisms in auxiliary nonessential recipient genes PLoS One 8 e74590 201310.1371/journal.pone.0074590377284224058593 Search in Google Scholar

90. Mumy K.L., Chen X., Kelly C.P., McCormick B.A.: Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G599–609 (2008) Mumy K.L. Chen X. Kelly C.P. McCormick B.A. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events Am. J. Physiol. Gastrointest. Liver Physiol. 294 G599 609 200810.1152/ajpgi.00391.2007321275418032477 Search in Google Scholar

91. Muñoz P., Bouza E., Cuenca-Estrella M., Eiros J.M., Pérez M.J., Sánchez-Somolinos M., Rincón C., Hortal J., Peláez T.: Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin. Infect. Dis. 40, 1625–1634 (2005) Muñoz P. Bouza E. Cuenca-Estrella M. Eiros J.M. Pérez M.J. Sánchez-Somolinos M. Rincón C. Hortal J. Peláez T. Saccharomyces cerevisiae fungemia: an emerging infectious disease Clin. Infect. Dis. 40 1625 1634 200510.1086/42991615889360 Search in Google Scholar

92. Murzyn A., Krasowska A., Augustyniak D., Majkowska-Skrobek G., Łukaszewicz M., Dziadkowiec D.: The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol. Lett. 310, 17–23 (2010) Murzyn A. Krasowska A. Augustyniak D. Majkowska-Skrobek G. Łukaszewicz M. Dziadkowiec D. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407 FEMS Microbiol. Lett. 310 17 23 201010.1111/j.1574-6968.2010.02037.x20629753 Search in Google Scholar

93. Niault M., Thomas F., Prost J., Ansari F.H., Kalfon P.: Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin. Infect. Dis. 28, 930 (1999) Niault M. Thomas F. Prost J. Ansari F.H. Kalfon P. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii Clin. Infect. Dis. 28 930 199910.1086/51725510825077 Search in Google Scholar

94. Perapoch J., Planes A.M., Querol A., López V., Martínez-Bendayán I., Tormo R., Fernández F., Peguero G., Salcedo S.: Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur. J. Clin. Microbiol. Infect. Dis. 19, 468–470 (2000) Perapoch J. Planes A.M. Querol A. López V. Martínez-Bendayán I. Tormo R. Fernández F. Peguero G. Salcedo S. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura Eur. J. Clin. Microbiol. Infect. Dis. 19 468 470 200010.1007/s10096000029510947224 Search in Google Scholar

95. Pérez-Torrado R., Querol A.: Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products. Front. Microbiol. 6, 1522 (2015) Pérez-Torrado R. Querol A. Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products Front. Microbiol. 6 1522 201510.3389/fmicb.2015.01522470530226779173 Search in Google Scholar

96. Piechno S., Seguin P., Gangneux J.P.: [Saccharomyces boulardii fungal sepsis: beware of the yeast]. Can. J. Anaesth. 54, 245–246 (2007) Piechno S. Seguin P. Gangneux J.P. [Saccharomyces boulardii fungal sepsis: beware of the yeast] Can. J. Anaesth. 54 245 246 200710.1007/BF0302265017331940 Search in Google Scholar

97. Pletincx M., Legein J., Vandenplas Y.: Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J. Pediatr. Gastroenterol. Nutr. 21, 113–115 (1995) Pletincx M. Legein J. Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea J. Pediatr. Gastroenterol. Nutr. 21 113 115 199510.1097/00005176-199507000-000228576803 Search in Google Scholar

98. Pothoulakis C., Kelly C.P., Joshi M.A., Gao N., O’Keane C.J., Castagliuolo I., Lamont J.T.: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 104, 1108–1115 (1993) Pothoulakis C. Kelly C.P. Joshi M.A. Gao N. O’Keane C.J. Castagliuolo I. Lamont J.T. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum Gastroenterology 104 1108 1115 199310.1016/0016-5085(93)90280-P Search in Google Scholar

99. Psomas E., Andrighetto C., Litopoulou-Tzanetaki E., Lombardi A., Tzanetakis N.: Some probiotic properties of yeast isolates from infant faeces and Feta cheese. Int. J. Food Microbiol. 69, 125–133 (2001) Psomas E. Andrighetto C. Litopoulou-Tzanetaki E. Lombardi A. Tzanetakis N. Some probiotic properties of yeast isolates from infant faeces and Feta cheese Int. J. Food Microbiol. 69 125 133 200110.1016/S0168-1605(01)00580-311589551 Search in Google Scholar

100. Rajkowska K., Kunicka-Styczyńska A.: Phenotypic and genotypic characterization of probiotic yeasts. Biotechnol. Biotec. Eq. 23, 662–665 (2009) Rajkowska K. Kunicka-Styczyńska A. Phenotypic and genotypic characterization of probiotic yeasts Biotechnol. Biotec. Eq. 23 662 665 200910.1080/13102818.2009.10818511 Search in Google Scholar

101. Rijnders B.J., Van Wijngaerden E., Verwaest C., Peetermans W.E.: Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med. 26, 825 (2000) Rijnders B.J. Van Wijngaerden E. Verwaest C. Peetermans W.E. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host Intensive Care Med. 26 825 200010.1007/s00134005126110945412 Search in Google Scholar

102. Riquelme A.J., Calvo M.A., Guzmán A.M., Depix M.S., García P., Pérez C., Arrese M., Labarca J.A.: Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J. Clin. Gastroenterol. 36, 41–43 (2003) Riquelme A.J. Calvo M.A. Guzmán A.M. Depix M.S. García P. Pérez C. Arrese M. Labarca J.A. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients J. Clin. Gastroenterol. 36 41 43 200310.1097/00004836-200301000-0001312488707 Search in Google Scholar

103. Robak M., Walczak E.: Niekonwencjonalne drożdże w produkcji heterologicznych białek. Biotechnologia, 87, 20 (2009) Robak M. Walczak E. Niekonwencjonalne drożdże w produkcji heterologicznych białek Biotechnologia 87 20 2009 Search in Google Scholar

104. Rodrigues A.C., Cara D.C., Fretez S.H., Cunha F.Q., Viera E.C., Nicoli J.R., Viera L.Q.: Saccharomyces boulardii stimulates sIgA production and the pahgocytic system of gnobiotic mice. J. Appl. Microbiol. 89, 404–414 (2000) Rodrigues A.C. Cara D.C. Fretez S.H. Cunha F.Q. Viera E.C. Nicoli J.R. Viera L.Q. Saccharomyces boulardii stimulates sIgA production and the pahgocytic system of gnobiotic mice J. Appl. Microbiol. 89 404 414 200010.1046/j.1365-2672.2000.01128.x11021572 Search in Google Scholar

105. Romanio M.R., Coraine L.A., Maielo V.P., Abramczyc M.L., Souza R.L., Oliveira N.F.: Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev. Paul. Pediatr. 35, 361–364 (2017) Romanio M.R. Coraine L.A. Maielo V.P. Abramczyc M.L. Souza R.L. Oliveira N.F. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics Rev. Paul. Pediatr. 35 361 364 201710.1590/1984-0462/;2017;35;3;00014 Search in Google Scholar

106. Roy U., Jessani L.G., Rudramurthy S.M., Gopalakrishnan R., Dutta S., Chakravarty C., Jillwin J., Chakrabarti A.: Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses, 60, 375–380 (2017) Roy U. Jessani L.G. Rudramurthy S.M. Gopalakrishnan R. Dutta S. Chakravarty C. Jillwin J. Chakrabarti A. Seven cases of Saccharomyces fungaemia related to use of probiotics Mycoses 60 375 380 201710.1111/myc.12604 Search in Google Scholar

107. Saegusa S., Totsuka M., Kaminogawa S., Hosoi T.: Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol. Med. Microbiol. 41, 227–235 (2004) Saegusa S. Totsuka M. Kaminogawa S. Hosoi T. Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid FEMS Immunol. Med. Microbiol. 41 227 235 200410.1016/j.femsim.2004.03.006 Search in Google Scholar

108. Salonen J.H., Richardson M.D., Gallacher K., Issakainen J., Helenius H., Lehtonen O.P., Nikoskelainen J.: Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. J. Hosp. Infect. 45, 293–301 (2000) Salonen J.H. Richardson M.D. Gallacher K. Issakainen J. Helenius H. Lehtonen O.P. Nikoskelainen J. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae J. Hosp. Infect. 45 293 301 200010.1053/jhin.1999.0718 Search in Google Scholar

109. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E.: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6, 374–382 (2006) Sazawal S. Hiremath G. Dhingra U. Malik P. Deb S. Black R.E. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials Lancet Infect. Dis. 6 374 382 200610.1016/S1473-3099(06)70495-9 Search in Google Scholar

110. Schneider S.M., Le Gall P., Girard-Pipau F., Piche T., Pompei A., Nano J.L., Hébuterne X., Rampal P.: Total artificial nutrition is associated with major changes in the fecal flora. Eur. J. Nutr. 39, 248–255 (2000) Schneider S.M. Le Gall P. Girard-Pipau F. Piche T. Pompei A. Nano J.L. Hébuterne X. Rampal P. Total artificial nutrition is associated with major changes in the fecal flora Eur. J. Nutr. 39 248 255 200010.1007/s003940070003 Search in Google Scholar

111. Shen N.T., Maw A., Tmanova L.L., Pino A., Ancy K., Crawford C.V., Simon M.S., Evans A.T.: Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: A systematic review with meta-regression analysis. Gastroenterology, 152, 1889–1900 (2017) Shen N.T. Maw A. Tmanova L.L. Pino A. Ancy K. Crawford C.V. Simon M.S. Evans A.T. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: A systematic review with meta-regression analysis Gastroenterology 152 1889 1900 201710.1053/j.gastro.2017.02.003 Search in Google Scholar

112. Smith D., Metzgar D., Wills C., Fierer J.: Fatal Saccharomyces cerevisiae aortic graft infection. J. Clin. Microbiol. 40, 2691–2692 (2002) Smith D. Metzgar D. Wills C. Fierer J. Fatal Saccharomyces cerevisiae aortic graft infection J. Clin. Microbiol. 40 2691 2692 200210.1128/JCM.40.7.2691-2692.2002 Search in Google Scholar

113. Sulik-Tyszka B., Wróblewska M. i wsp.: Experience with Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics Antimicrob. Proteins, 10, 350–355 (2018) Sulik-Tyszka B. Wróblewska M. i wsp. Experience with Saccharomyces boulardii probiotic in oncohaematological patients Probiotics Antimicrob. Proteins 10 350 355 201810.1007/s12602-017-9332-4 Search in Google Scholar

114. Surawicz C.M., Elmer G.W. i wsp.: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31, 1012–1017 (2000) Surawicz C.M. Elmer G.W. i wsp. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii Clin. Infect. Dis. 31 1012 1017 200010.1086/318130 Search in Google Scholar

115. Szajewska H., Kołodziej M., Zalewski B.M.: Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children – a 2020 update. Aliment. Pharmacol. Ther. 51, 678–88 (2020) Szajewska H. Kołodziej M. Zalewski B.M. Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children – a 2020 update Aliment. Pharmacol. Ther. 51 678 88 202010.1111/apt.1565932056266 Search in Google Scholar

116. Tanaka H., Kamogawa T., Aoyagi H., Kato I., Nakajima R.: Invertase production by Saccharomyces cerevisiae protoplasts immobilized in strontium alginate gel beads. J. Biosci. Bioeng. 89, 498–500 (2000) Tanaka H. Kamogawa T. Aoyagi H. Kato I. Nakajima R. Invertase production by Saccharomyces cerevisiae protoplasts immobilized in strontium alginate gel beads J. Biosci. Bioeng. 89 498 500 200010.1016/S1389-1723(00)89105-7 Search in Google Scholar

117. Thygesen J.B., Glerup H., Tarp B.: Saccharomyces boulardii fungemia caused by treatment with a probioticum. BMJ Case Rep. bcr0620114412 (2012) Thygesen J.B. Glerup H. Tarp B. Saccharomyces boulardii fungemia caused by treatment with a probioticum BMJ Case Rep. bcr0620114412 201210.1136/bcr.06.2011.4412331679922605806 Search in Google Scholar

118. Tiago F.C.P., Martins F.S., Souza E.L.S., Pimenta P.F.P., Araujo H.R.C., Castro I.M., Brandão R.L., Nicoli J.R.: Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J. Med. Microbiol. 61, 1194–1207 (2012) Tiago F.C.P. Martins F.S. Souza E.L.S. Pimenta P.F.P. Araujo H.R.C. Castro I.M. Brandão R.L. Nicoli J.R. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics J. Med. Microbiol. 61 1194 1207 201210.1099/jmm.0.042283-022580913 Search in Google Scholar

119. Topaloğlu U., Yilmazcan A., Güloğlu R., Taşçioğlu J., Müftüoğlu T., Unalmişer S.: Hypertonic saline prevents early bacterial translocation in hemorrhagic shock. Surg. Today, 29, 47–50 (1999) Topaloğlu U. Yilmazcan A. Güloğlu R. Taşçioğlu J. Müftüoğlu T. Unalmişer S. Hypertonic saline prevents early bacterial translocation in hemorrhagic shock Surg. Today 29 47 50 199910.1007/BF024829699934831 Search in Google Scholar

120. van der Aa Kühle A., Jespersen L.: The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst. Appl. Microbiol. 26, 564–571 (2003) van der Aa Kühle A. Jespersen L. The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene Syst. Appl. Microbiol. 26 564 571 200310.1078/07232020377086587314666985 Search in Google Scholar

121. Vaughan-Martini A., Martini A.: Facts, myths and legends on the prime industrial microorganism. J. Ind. Microbiol. 14, 514–522 (1995) Vaughan-Martini A. Martini A. Facts, myths and legends on the prime industrial microorganism J. Ind. Microbiol. 14 514 522 199510.1007/BF015739677662293 Search in Google Scholar

122. Viggiano M., Badetti C., Bernini V., Garabedian M., Manelli J.C.: [Saccharomyces boulardii fungemia in a patient with severe burns]. Ann. Fr. Anesth. Reanim. 14, 356–358 (1995) Viggiano M. Badetti C. Bernini V. Garabedian M. Manelli J.C. [Saccharomyces boulardii fungemia in a patient with severe burns] Ann. Fr. Anesth. Reanim. 14 356 358 199510.1016/S0750-7658(05)80603-3 Search in Google Scholar

123. Williams J.G., Kubelik A.R., Livak K.J., Rafalski J.A., Tingey S.V.: DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18, 6531–6535 (1990) Williams J.G. Kubelik A.R. Livak K.J. Rafalski J.A. Tingey S.V. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers Nucleic Acids Res. 18 6531 6535 199010.1093/nar/18.22.65313326061979162 Search in Google Scholar

124. Zunic P., Lacotte J., Pegoix M., Buteux G., Leroy G., Mosquet B., Moulin M.: [Saccharomyces boulardii fungemia. Apropos of a case]. Therapie, 46, 498–499 (1991) Zunic P. Lacotte J. Pegoix M. Buteux G. Leroy G. Mosquet B. Moulin M. [Saccharomyces boulardii fungemia. Apropos of a case] Therapie 46 498 499 1991 Search in Google Scholar

eISSN:: 2545-3149
Sprachen:: Englisch, Polnisch

Zeitrahmen der Veröffentlichung:: 4 Hefte pro Jahr
Fachgebiete der Zeitschrift:: Biologie, Mikrobiologie und Virologie

Zeitschrift RSS Feed